![](/img/cover-not-exists.png)
Real-world study of afatinib in first-line or re-challenge settings for patients with EGFR mutant non-small cell lung cancer
Tanaka, Hisashi, Taima, Kageaki, Itoga, Masamichi, Ishioka, Yoshiko, Baba, Keisuke, Shiratori, Toshihiro, Sakamoto, Hiroaki, Tsuchiya, Junichiro, Nakagawa, Hideyuki, Hasegawa, Yukihiro, Yasugahira, HiVolume:
36
Language:
english
Journal:
Medical Oncology
DOI:
10.1007/s12032-019-1278-9
Date:
June, 2019
File:
PDF, 1010 KB
english, 2019